NCT02213900View on ClinicalTrials.gov

Preventing Post-Operative Delirium in Patients Undergoing a Pneumonectomy, Esophagectomy or Thoracotomy

PHASE4CompletedINTERVENTIONAL

Enrollment

135

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions

DeliriumCognitive ImpairmentPost-traumatic Stress DisorderDepressionAnxiety

Interventions

DRUG

Haloperidol

0.5mg IV Push immediately after surgery and Q8H following for a total of 4 days

DRUG

Placebo

Trial Locations (1)

46202

University Hospital, Indianapolis

All Listed Sponsors

lead

Indiana University

OTHER

NCT02213900 - Preventing Post-Operative Delirium in Patients Undergoing a Pneumonectomy, Esophagectomy or Thoracotomy | Biotech Hunter | Biotech Hunter